semaglutide fda ban The FDA's Decision to Compounds: What You Need to Know The FDA Just Banned Compounded

Retatrutides innovation is combining glucagon activation with sufficient GLP-1 activity to offset hyperglycemic effects

Melanotan I (afamelanotide) binds to the melanocortin I receptor (MC1R) to promote melanogenesis, both by proliferation of melanocytes and by regulation of tyrosinase activity

At 2.5 mg/mL, 20 units delivers only 0.5 mg, which is a standard early-phase dose

Berberine is a plant-derived compound traditionally used in Ayurvedic and Chinese herbal medicine

Sulfur burps can be an unpleasant but often temporary side effect of GLP-1 medications

Patients with atrial arrhythmias had risk factors for occurrence and continuation of arrhythmias: they were significantly older, more often had obesity, a history of AF and LV hypertrophy and were current tobacco users